Related by context. All words. (Click for frequent words.) 69 de novo kidney transplant 69 Vitrasert R 68 Crofelemer budesonide foam 68 receiving XGEVA 68 Begins Dosing 68 ACTEMRA TM 67 active ankylosing spondylitis 67 Phase 2b Clinical Trial 67 homozygous familial hypercholesterolemia 67 Meets Primary Endpoint 67 Omacetaxine 67 lintuzumab SGN 67 Pivotal Phase III 67 steroid refractory ulcerative 67 esophageal candidiasis 67 Investigational Treatment 67 bone marrow reticulin deposition 67 severe oral mucositis 67 evaluating Prochymal 67 Ribavirin causes 67 PEGylated Fab fragment 67 Pegloticase 66 Initiates Enrollment 66 reduce serum phosphate 66 Initiates Phase II 66 eosinophilic asthma 66 systemic anaplastic large 66 FUSILEV enhances 66 dasatinib Sprycel ® 66 Refractory Hodgkin Lymphoma 66 receiving chemoradiation therapy 66 basiliximab 66 myocardial infarction ventricular fibrillation 66 TM pralatrexate injection 66 methylnaltrexone bromide 66 non splenectomized 66 catheter occlusion 66 hypereosinophilic syndrome 66 LymphoStat B belimumab 66 Completes Patient Enrollment 66 deep venous thromboses 66 myelodysplastic myeloproliferative diseases 66 refractory gout 66 R lenalidomide 66 headache nasopharyngitis 66 Trial Evaluating 66 Budesonide foam crofelemer 66 carcinoma mCRC 66 debilitating complication 66 Initiate Phase 65 evaluating picoplatin 65 TNF Tumor Necrosis Factor 65 relapsing remitting MS RRMS 65 mitoxantrone plus 65 Amgen Neulasta R 65 Oral Calcitonin 65 highly purified pasteurized 65 Achieves Primary Endpoint 65 gastrointestinal mucositis 65 ® lenalidomide 65 approved incretin mimetic 65 dyslipidemia hypertension diabetes 65 diabetic peripheral neuropathic DPN 65 oxypurinol 65 Mylan Receives Approval 65 MKC# MT 65 metastatic GIST 65 VEGFR2 inhibitor 65 neutropenia dehydration dyspnea 65 metastatic malignant 65 pralatrexate injection folate analogue 65 relapsed MM 65 PLX STROKE targeting 65 retinal vein occlusion induced 65 Prochymal TM 65 indolent follicular non 65 GVAX ® 65 relapsed leukemia 65 psoriasis rheumatoid arthritis 65 BCG refractory carcinoma 65 immune thrombocytopenic purpura ITP 65 Mg Usa 65 kidney urologic 65 refractory chronic lymphocytic 65 radiation enteritis 65 Initiates Phase III 65 Amigal TM 65 MAGE A3 ASCI 65 investigational monoclonal antibody 65 Telik logo TELINTRA 65 EVIZON TM 65 alfa 2a 65 Granted Orphan Drug 65 SPRYCEL ® 65 monoclonal antibody IgG1 Mab 65 resistant hormone refractory 65 pediatric Crohn disease 64 occlusion PAO 64 Phase Ib IIa 64 Behcet uveitis 64 CYT# potent vascular disrupting 64 humanized therapeutic 64 tumors GIST 64 Aflibercept 64 Kit CD# positive 64 Pivotal Phase 64 purpura ITP 64 idiopathic thrombocytopenic purpura ITP 64 recurrent glioblastoma multiforme 64 hypertrichosis occurred 64 arthritis PsA 64 Abrupt discontinuation 64 ® adefovir dipivoxil 64 PNP inhibitor 64 Peginterferon alfa 2b 64 rheumatoid arthritis psoriatic arthritis 64 class mGluR5 inhibitor 64 MKC# 64 severe malignant osteopetrosis 64 humanised monoclonal antibody 64 Submits Response 64 TAXOTERE ® 64 Glioblastoma Multiforme 64 venous stasis ulcers 64 antibody MAb 64 Demonstrates Positive 64 Second Pivotal Phase 64 XL# anticancer compounds 64 invasive candidiasis 64 pseudobulbar affect PBA 64 SUPPRELIN R LA 64 biologic antibody 64 Amgen Neulasta ® 64 included exfoliative dermatitis 64 Known hypersensitivity 64 paroxysmal supraventricular tachycardia 64 thetreatment 64 baminercept 64 Bayer HealthCare Onyx Pharmaceuticals 64 Patients Treated With 64 humanized interleukin 6 64 Randomized Phase 64 acute GvHD 64 HGS ETR1 mapatumumab 64 hematological cancers notably 64 Presents Positive 64 Vitrasert ® 64 adult chronic ITP 64 phase III isavuconazole 64 adalimumab Humira 64 Dementia Related Psychosis 64 Idiopathic Pulmonary Fibrosis 64 albiglutide 64 Fast Track Status 64 nephropathic cystinosis cystinosis 64 novel orally inhaled 64 Severe VOD 64 ThermoDox R 64 HeFH 64 refractory NSCLC 64 compound INCB# 64 cutaneous T 64 Vidaza ® 64 chronic granulomatous disease 64 receptor tyrosine kinase inhibitor 63 acetonide FA 63 monoclonal antibody conjugated 63 induced macular edema 63 smoldering multiple myeloma 63 Atypical Hemolytic Uremic Syndrome 63 Severe Sepsis 63 RANK Ligand inhibitor 63 R sorafenib tablets 63 leukemia AML 63 evaluating tivozanib 63 nanofiltered plasma derived 63 oropharyngeal candidiasis OPC 63 steroid refractory 63 toenail onychomycosis 63 dose intramuscular 63 Golimumab 63 Primary Hypercholesterolemia 63 TransVax 63 idiopathic thrombocytopenic purpura 63 systemic juvenile idiopathic 63 R vitespen 63 acute mania 63 oral prodrug 63 influenza BCX# purine nucleoside 63 Patient Enrollment 63 essential thrombocythemia ET 63 TTR amyloidosis 63 treat chronic sinusitis 63 Friedreich Ataxia FRDA 63 commercializes innovative biopharmaceuticals 63 oral nucleoside analogue 63 aflibercept VEGF Trap 63 either acutely decompensated 63 plus prednisone prednisolone 63 Fabry Disease 63 treatment naive genotype 63 demonstrated antitumor activity 63 haematologic 63 renal failure interstitial lung 63 Hormone Refractory Prostate Cancer 63 opioid naive 63 hyperphenylalaninemia HPA due 63 recurrent metastatic ovarian cancer 63 allosteric modulator PAM 63 orally administered inhibitor 63 complement inhibitor eculizumab 63 acyclovir Lauriad R 63 nephropathic cystinosis 63 Naive Patients 63 investigational oral hepatitis C 63 Cimzia TM 63 Acute Exacerbations 63 atypical Hemolytic Uremic Syndrome 63 Infusion Reactions Severe 63 DIFICID ™ 63 brand ciclesonide HFA 63 Orphan Status 63 FOLOTYN ® 63 Idiopathic Pulmonary Fibrosis IPF 63 Ecallantide 63 BioMarin develops 63 diabetic gastroparesis 63 Advanced Melanoma 63 BRIM2 63 treat atrial flutter 63 tumor lysis syndrome 63 Sudhir Agrawal D.Phil 63 Phase IIb Trial 63 forodesine 63 CYP#A# substrate 63 CIMZIA r certolizumab pegol 63 NASH Huntington 63 LymphoStat B TM 63 neurogenic orthostatic hypotension 63 minimally symptomatic 63 dexanabinol 63 Darinaparsin 63 oxymorphone ER 63 exocrine pancreatic insufficiency EPI 63 opioid induced bowel dysfunction 63 RAPTIVA 63 selective A2A adenosine receptor 63 Submits Biologics License Application 63 successfully commercialize Iluvien 63 combining voreloxin 63 erlotinib Tarceva ® 63 zoledronic acid Reclast 63 Hepatocellular Carcinoma HCC 63 advanced carcinoid 63 heFH 63 Lactic acidosis 63 PF # [002] 63 severe hypersensitivity reactions 63 hormone refractory metastatic prostate 63 Host Disease 62 IMiDs ® 62 gastrointestinal stromal tumor GIST 62 Adjuvant Treatment 62 diabetic neuropathic pain 62 Combination REOLYSIN R 62 induced mucositis 62 terlipressin 62 gastrointestinal GI motility disorders 62 pain palliation 62 chronic immune thrombocytopenic 62 chronic thromboembolic pulmonary 62 erythematosus 62 immune idiopathic thrombocytopenic 62 Receives Orphan Drug Designation 62 containing abacavir 62 gastrointestinal stromal 62 Aryplase 62 Postherpetic neuralgia PHN 62 oral picoplatin 62 cancer neuroendocrine tumor 62 Central Retinal Vein 62 FDA Accepts 62 CYP#A# CYP#D# 62 lomitapide 62 Panzem R 62 IL# PE#QQR 62 huC# DM4 62 neuropathic pain spasticity 62 AVASTIN 62 infectious diseases autoimmune diseases 62 OMP #R# 62 Retisert ® 62 nilotinib Tasigna ® 62 Prestara 62 chronic idiopathic thrombocytopenic purpura 62 receiving immunosuppressive therapy 62 neutropenia thrombocytopenia 62 KIACTA ™ 62 diabetic kidney 62 prolonged cytopenias 62 Pulmonary Arterial Hypertension PAH 62 novel synthetic PEGylated 62 Prodarsan R 62 Cerebril TM 62 post herpetic neuralgia PHN 62 Xelox 62 PRN FDA Approves 62 modified glutathione analog 62 metastatic renal 62 SinuNase TM 62 MELAS 62 Phase IIb Clinical Trial 62 investigational oral inhibitor 62 Daclizumab 62 Myelofibrosis 62 structure infections ABSSSI 62 prescribed proton pump 62 Acute Bacterial Sinusitis ABS 62 non nucleoside inhibitor 62 Biogen Genentech 62 Metastatic Melanoma 62 rheumatoid arthritis osteoarthritis ankylosing 62 Acute Myelogenous Leukemia AML 62 rheumatoid arthritis RA psoriatic 62 Phase 2b Trial 62 hypercholesterolemic patients 62 eritoran 62 including eniluracil ADH 62 GvHD 62 R abatacept 62 Romiplostim 62 Empatic ™ 62 sitaxsentan 62 CIMZIA TM certolizumab pegol 62 invasive aspergillosis 62 lenalidomide Revlimid R 62 diarrhea predominant irritable 62 potentially hepatotoxic 62 naïve HCV 62 neutropenic sepsis 62 systemic lupus erythematosus psoriasis 62 Mg Uk 62 Dosa suffers 62 Initiate Phase III 62 Adenoviruses usually cause 62 Vascugel 62 factor TNF receptor 62 familial amyloidotic polyneuropathy FAP 62 acute peripheral arterial 62 ospemifene 62 vascular occlusive diseases 62 recurrent glioblastoma 62 Ophena TM 62 Acneform rash occurred 62 Folfox 62 Vascular Disrupting Agent 62 non metastatic osteosarcoma 62 BENLYSTA ® 62 R Saizen R 62 OMNARIS HFA 62 metastatic renal cell 62 IAP inhibitor 62 recombinant PSMA vaccine 62 Files IND 62 oxaliplatin Eloxatin 62 Kepivance 62 infection sinusitis 62 recurrent malignant glioma 62 Somatuline Depot 62 including acne photodamage 62 Soft Tissue Sarcoma 62 Paliperidone Palmitate 62 sulfonylurea glimepiride 62 unresectable HCC 62 triggers apoptosis programmed 62 Submits NDA 62 Hodgkin lymphoma HL 62 candidate XP# 62 Pruvel TM 62 taxane chemotherapy administered 62 II Clinical Trial 62 novel VDA molecule 62 personalized cellular immunotherapy 62 budesonide foam 62 Treatment Naive Patients 62 high intensity oncologic 62 Testosterone MDTS ® 62 severe gastroparesis 62 Prolongs Survival 62 Newly Diagnosed Multiple Myeloma 62 sorafenib tablets 62 IIa Clinical Trial 62 polycythemia vera essential thrombocythemia 62 Degarelix 62 generation purine nucleoside 62 dermatologic reactions 62 treatment naïve genotype 62 ® bortezomib 62 cell carcinoma RCC 62 rhIGF-I/rhIGFBP-3 62 Infusion reactions 62 Desvenlafaxine Succinate 62 pharmacogenomic translational research 62 neuromuscular spasm 62 Recurrent Glioblastoma 62 overactive bladder syndrome 62 Investigational Oral 62 anthracycline taxane 62 treats paroxysmal nocturnal 62 Dose Ranging Study 62 respiratory allergy dermatological 61 novel tubulin binding 61 novel emulsion formulation 61 herpetic keratitis 61 PEGINTRON REBETOL combination 61 KRN# 61 XL# SAR# 61 dirucotide MBP# 61 INTEGRILIN R 61 evaluating mipomersen 61 Initiates Clinical 61 unresectable stage 61 delivers fluocinolone acetonide FA 61 Improves Outcomes 61 Muraglitazar 61 Fibrin Pad 61 evaluating T DM1 61 cisplatin chemotherapy 61 patients coinfected 61 NU# direct 61 Initiates Clinical Trial 61 nasal calcitonin product 61 imatinib Gleevec ® 61 vapreotide acetate 61 5 fluorouracil leucovorin 61 metformin accumulation 61 anthracyclines taxanes 61 systemic fungal infections 61 inflammatory PDE 61 Troxatyl 61 psoriasis Crohn disease 61 mGluR2 positive 61 icatibant 61 Completes Enrollment 61 HIV treatments Reyataz 61 headache abdominal pain 61 psoriatic arthritis PsA 61 Vicinium TM 61 Intravitreal 61 hoFH 61 Onyx Pharmaceuticals Announces 61 debilitating autoimmune 61 stable angina pectoris 61 dextromethorphan quinidine 61 dual endothelin receptor antagonist 61 recurrent metastatic 61 Fx #A 61 TNF antagonist 61 thrombocytopenia neutropenia 61 virus HCV protease inhibitor 61 DEB# 61 chronic eosinophilic leukemia 61 Mucositis 61 ZOLINZA 61 gastrointestinal reflux 61 Gemzar gemcitabine 61 Treatment Shows Promise 61 EVIZON ™ 61 Cethromycin 61 galiximab 61 keloid scarring 61 Efficacy Results 61 reversing heparin 61 Myelodysplastic Syndrome MDS 61 INSPIRE Trial Phase III 61 Tramiprosate ALZHEMED TM 61 calcineurin inhibitor 61 Offering Pilates 61 mRCC 61 Evoltra ® 61 Testosterone MDTS R 61 Erythropoietic therapies may 61 Methylnaltrexone 61 relapsed refractory multiple myeloma 61 PEGINTRON TM 61 PRECISE Trial 61 vWD 61 midstage clinical 61 Pivotal Clinical Trial 61 heterozygous FH 61 Xcytrin R 61 delivers preprogrammed intermittent 61 oral dual endothelin 61 nucleotide analog 61 pouchitis 61 TTF Therapy 61 distal embolization thrombus formation 61 Malignant Glioma 61 chronic ITP patients 61 Aeolus Pharmaceuticals Announces 61 SNT-MC#/idebenone 61 relapsed CLL 61 Acute myeloid leukemia 61 myalgia arthralgia 61 TRIOLEX HE# APOPTONE HE# 61 transplantation HCT 61 Complicated Skin 61 rALLy 61 Silodosin 61 symptomatic neurogenic orthostatic hypotension 61 benign prostatic hypertrophy BPH 61 Lupus nephritis 61 Brentuximab Vedotin SGN 61 agonistic human 61 Neovascular Age Related Macular 61 rasagiline tablets 61 Vicriviroc 61 Efficacy Trial 61 unresectable malignant mesothelioma UMM 61 developing Bicifadine serotonin 61 dimebon latrepirdine 61 CDAD Clostridium difficile 61 Leukopenia neutropenia 61 hypertension systolic blood 61 Phase #b/#a clinical 61 sunitinib malate 61 IMPDH inhibitor 61 Dose Escalation 61 Glioblastoma multiforme GBM 61 metastatic ocular 61 cisplatin gemcitabine 61 Endologix Powerlink System 61 Camptosar ® 61 Albuferon TM 61 Announces Tentative Approval 61 Forodesine HCl 61 Telavancin 61 HoFH 61 Annamycin 61 Phase 2a Trial 61 Gleevec resistant 61 post herpetic 61 OHR/AVR# 61 Submits Supplemental 61 Laquinimod 61 GATTEX TM 61 FACTIVE ® 61 relapsed ALL 61 severe neutropenia 61 Sprycel dasatinib 61 Congenital Emphysema 61 allogenic stem cell 61 dependent kinase inhibitor 61 NAVISTAR R 61 5 lipoxygenase inhibitor 61 Chronic Hepatitis C 61 selective modulator 61 chemosensitizer 61 Acute Radiation Syndrome ARS 61 patients receiving myelosuppressive 61 anthracycline containing 61 metastatic colorectal 61 CTAP# 61 reslizumab 61 Toremifene 61 opioid induced constipation OIC 61 palonosetron hydrochloride Injection Dacogen 61 HCV NS5B polymerase 61 IV APAP 61 Unstable Angina 61 rALLy clinical trial 61 Cloretazine ® 61 Diamyd r 61 chemotherapy induced neutropenia 61 intravenous RSD# 61 Lymphocytic 61 MKC# MKC# PP 61 epiglottitis 61 refractory cutaneous T 61 evaluate ZFP Therapeutic 61 Launches Generic Version 61 phase IIb study 61 bacterial exacerbation 61 receptor inhibiting monoclonal 61 oral rivaroxaban 61 cytomegalovirus immune globulin 61 Noxafil 61 cSSSIs 61 atypical hemolytic uremic syndrome 60 includes TOLAMBA TM 60 Presents Preclinical 60 related CMV Retinitis 60 Talabostat 60 anti botulism antibody 60 Dermatologic toxicities 60 relapsed multiple myeloma 60 Chronic Myeloid Leukemia 60 novel therapeutic antibodies 60 docetaxel Taxotere ® 60 novel histone deacetylase 60 chronic rheumatic 60 undergoing elective percutaneous 60 ALN VSP Phase 60 Vidaza azacitidine 60 Entereg R 60 Epothilone D 60 Initiate Clinical Trial 60 ALN HPN 60 rheumatoid arthritis inflammatory bowel 60 Cutaneous T 60 progressive metastatic prostate 60 sunitinib Sutent 60 ZEGERID Chewable Tablets 60 uterine fibroids endometriosis 60 multiple sclerosis psoriasis 60 Receives Orphan Drug 60 forodesine purine nucleoside phosphorylase 60 refractory myeloma 60 CTAP# Capsules 60 Phase III Clinical Trial 60 COPEGUS R 60 albiglutide currently 60 allogeneic bone marrow 60 vinorelbine tartrate 60 BENLYSTA TM 60 AAG geldanamycin analog 60 AN# topical anti 60 Allovectin 7 60 genitourinary GU 60 Archexin 60 CYP#A# isoenzyme 60 elotuzumab 60 Esophagitis 60 severe hypercholesterolemia 60 NEBIDO VANTAS SUPPRELIN LA 60 Belimumab 60 FOLFIRI alone 60 Pivotal Trial 60 proprietary intravenous formulation 60 Mipomersen 60 SUTENT ® 60 Temodar ® 60 MPS IVA 60 selective phosphodiesterase 60 JAK2 Inhibitor 60 Pruvel 60 novel oral anticoagulant 60 phase IIb clinical 60 TELINTRA R 60 indolent NHL 60 Fingolimod 60 Bezielle 60 moderate renal impairment 60 Gabapentin enacarbil 60 Pivotal Study 60 Pruvel ™ prulifloxacin 60 AVAPRO 60 candidemia 60 hepatorenal syndrome 60 Myelodysplastic Syndrome 60 volociximab 60 Phenoptin 60 smoldering myeloma 60 KRAS mutant tumors 60 Acute Bacterial Skin 60 Therapies SRT 60 REGN# 60 Juvenile Idiopathic Arthritis 60 investigational humanized monoclonal antibody 60 Tibotec Therapeutics division 60 R adefovir dipivoxil 60 chronic HBV 60 metastatic kidney 60 therapeutically inactive prodrug 60 Systemic lupus erythematosus SLE 60 Follicular Lymphoma 60 intravascular hemolysis 60 Alair Bronchial Thermoplasty System 60 assessing T DM1 60 Hypoactive Sexual Desire Disorder 60 Vertex hepatitis C 60 ELACYT 60 Cabazitaxel 60 recurrent glioblastoma multiforme GBM 60 Demonstrates Significant 60 aerosolized AAT 60 Shows Promise Against 60 bleeding pallor 60 antiangiogenesis therapies 60 acute PAO 60 PEGylated docetaxel 60 Alessandro Riva 60 Study Shows Promise 60 zileuton IV 60 anagrelide 60 Nicole Onetto MD 60 signal detection CTSD 60 IBS C 60 post transplant lymphoproliferative 60 D aspartate NMDA receptor 60 Frozen Shoulder syndrome Adhesive 60 Amrubicin 60 AEG# 60 CINQUIL 60 Zidovudine Tablets 60 TO AVOID PREGNANCY WHILE 60 NYHA Class II 60 Host Disease GvHD 60 6R BH4 60 cromolyn sodium 60 docetaxel Taxotere R 60 taxane chemotherapy 60 Tarvacin Anti Cancer 60 octreotide implant 60 NSABP C 60 Metastatic Colorectal Cancer 60 organ transplant rejection 60 initiated Phase Ib 60 ZACTIMA TM ZD# 60 Fast Track designations 60 arterial thrombosis 60 mild vasodilator 60 First Patient Enrolled 60 induce orthostatic hypotension 60 Bronchiectasis 60 Acute myelogenous leukemia 60 Eculizumab 60 biliary tract cancer 60 XP# XP# 60 diarrhea headache nausea 60 Perforomist ™ Inhalation Solution 60 Initiates Phase 60 gets USFDA nod 60 Panzem R NCD 60 intra abdominal infections 60 FOR FURTHER INFORMATION ABOUT 60 Inhaled nitric oxide 60 norepinephrine reuptake inhibitor 60 Bosutinib 60 Azmacort R 60 oropharyngeal candidiasis 60 XIAFLEX ® 60 IND Filing 60 failure NYHA 60 ATTR PN 60 motesanib 60 Commences Phase 60 Zenvia ™ 60 Relapsed Refractory 60 ocular inflammatory 60 metastatic dermatofibrosarcoma protuberans DFSP 60 ® decitabine 60 hypervascular tumors 60 Pralatrexate 60 Wafer polifeprosan 60 NV1FGF 60 Toxicities 60 CG# oncolytic virus 60 iGVHD 60 Plicera TM 60 ADP receptor antagonist 60 dihydrochloride Tablets 60 Phase III Trial 60 interferon beta 1a infertility 60 myelofibrosis MF 60 non porcine pancreatic 60 UPLYSO 60 R Bortezomib 60 NicVAX TM 60 targeted radiotherapeutic 60 interferon alpha IFN 60 particularly SANCTURA XR 60 thalidomide Thalomid 60 Coadministration 60 refractory Hodgkin 60 TELINTRA 60 OSI Tarceva 60 unstable angina UA 60 develop HBV reactivation 60 AA Amyloidosis 60 Liprotamase 60 everolimus tablets 60 Phase III Pivotal 60 constipation predominant irritable bowel 60 Genasense ® 60 osteolytic bone disease 60 refractory ovarian cancer 60 familial hypercholesterolemia FH 60 Temsirolimus 60 sodium thiosulfate STS 60 MEK Inhibitor 60 Bayer Nexavar 60 systemic invasive fungal 60 #mg ATC 60 Chronic lymphocytic leukemia 60 non constipating irritable 60 adjuvant GIST 60 serologically active systemic lupus 60 Gliadel R 60 Graft Versus Host 60 solanezumab 60 irinotecan doxorubicin oxaliplatin paclitaxel 60 Synta Announces 60 Hepatitis C HCV 60 Cloretazine 60 Relapsed Multiple Myeloma 60 asthma rheumatoid arthritis 60 progressive neurodegenerative 60 neurogenic bladder 60 peritumoral brain edema 60 NDA Submission 60 Vandetanib 60 refractory metastatic colorectal cancer 60 TYGACIL 60 ST Elevation Myocardial 60 idiopathic pulmonary fibrosis IPF 60 beta 1a 60 Paroxysmal Nocturnal Hemoglobinuria 60 Elagolix 60 interferon gamma 1b 59 anaphylactic reactions bronchospasm 59 Tyrosine Kinase Inhibitor 59 NS5B polymerase 59 RhuDex R 59 phase IIb trial 59 pre cancerous actinic 59 rufinamide 59 refractory acute myeloid 59 maximally tolerated lipid lowering 59 lucinactant 59 Ceflatonin R 59 medically refractory epilepsy 59 liver resection surgeries 59 venous thromboembolic events 59 gastro intestinal inflammation 59 drug NP2 Enkephalin 59 ELADUR ™ 59 Dacetuzumab 59 injected subcutaneously 59 Previously Untreated 59 FOLFOX6 chemotherapy regimen 59 heparin induced thrombocytopenia 59 cutaneous lupus 59 GTC recombinant form 59 lupus erythematosus 59 lupus nephritis 59 delayed CINV 59 manufactures minimally invasive 59 Cardium Therapeutics TM 59 sitaxsentan sodium 59 EVIZON TM squalamine lactate 59 MTP inhibitor 59 Aceon 59 vitreoretinal disorders 59 Hedgehog Pathway Inhibitor 59 Heterozygous Familial Hypercholesterolemia 59 Curaxin CBLC# 59 acute humoral rejection 59 Personalized Immunotherapy 59 hypertension pulmonary arterial 59 Nipent R 59 dasatinib Sprycel 59 ADL# novel 59 trial evaluating Prochymal 59 Anti VEGF 59 Teriflunomide 59 INCB# [001] 59 herpes zoster shingles 59 Proleukin 59 Ph + acute lymphoblastic 59 refractory chronic myeloid 59 PEG IFN 59 TAXUS Element Paclitaxel Eluting 59 ViaDerm hPTH #-# 59 cognitive impairment associated 59 immunodeficiency disorders 59 pemphigus vulgaris 59 prokinetic agent 59 ERBITUX cetuximab 59 phase Ib 59 Sodium oxybate 59 primary IGFD 59 Lenocta TM 59 Hos2 59 metastatic CRC 59 Limb Ischemia 59 Elesclomol 59 IV melanoma 59 pseudomembranous colitis 59 ENL recurrence 59 Pirfenidone 59 Recombinant interferon alpha 59 Initiated Phase 59 alkylating agent 59 PREZISTA r 59 patients undergoing percutaneous 59 C1 INH deficiency 59 Clinical Trial Results 59 Campath alemtuzumab 59 hour bronchodilation 59 ORENCIA R 59 autoimmune disorder characterized 59 hematological diseases 59 Xanafide 59 systemic ALCL 59 castration resistant hormone refractory 59 Elestrin ® 59 known dihydropyrimidine dehydrogenase 59 Lambert Eaton Myasthenic 59 Tavocept 59 CCR9 antagonist 59 docetaxel Taxotere 59 AIDS prophylaxis congestive 59 cough dyspnea 59 Horizant ™ 59 CIPN 59 Phase IIa Clinical Trial 59 Unit Dose Budesonide 59 metastatic carcinoid 59 Syncria R 59 receiving VELCADE 59 death dissection perforation 59 HQK 59 gastrointestinal disorders characterized 59 HIV coinfected 59 IMiDs R 59 solid tumors ZYBRESTAT 59 receiving INTRON 59 Previously Treated 59 gemifloxacin mesylate tablets fluoroquinolone 59 platinum refractory 59 Fast Track Designation 59 opioid bowel dysfunction 59 Cellegesic 59 intravesical infusion therapy 59 osteoarthritis rheumatoid arthritis 59 ATRA IV 59 complicated intra abdominal 59 Drug Prevents 59 chronic myeloid 59 relapsing multiple sclerosis 59 vaginal candidiasis 59 Fibrillex TM 59 Critical Limb Ischemia 59 Syncria albiglutide 59 resectable pancreatic cancer 59 SILENOR TM doxepin HCl 59 accompanying electrolyte abnormalities 59 Acute Myelogenous Leukemia 59 oral methylnaltrexone 59 retinal vein occlusion 59 TLR9 agonist IMO 59 failure thrombosis embolism 59 thrombin inhibiting aptamer 59 acute peptic ulcer 59 Epratuzumab 59 riociguat 59 diseases osteoarthritis osteoporosis 59 adjuvant colon cancer 59 Oral Fingolimod 59 commercialize deforolimus 59 Orally administered 59 evaluating Actimmune 59 PENTASA 59 Plaque Psoriasis 59 METOZOLV ™ ODT metoclopramide 59 overactive bladder AA# 59 pan histone deacetylase 59 treat opioid induced 59 AGILECT R 59 5 FU leucovorin 59 metastatic colorectal carcinoma 59 Hsp# Inhibitor 59 Diffuse Large B 59 Solzira TM 59 containing LABAs 59 Gel repository corticotropin injection 59 pamidronate 59 injectable investigational 59 lymphoma CTCL 59 unique alkylating agent 59 OAB overactive bladder 59 R memantine HCl 59 Pemetrexed 59 Parnate 59 TRANSDUR ® 59 Soliris TM eculizumab 59 failure ADHF 59 Peginterferon Alfa 2a 59 Initiates Phase 2b 59 Zollinger Ellison Syndrome 59 Renal Impairment 59 Phase 2b Study 59 Novel Oral 59 azilsartan medoxomil 59 leukemia APL 59 Diabetic Macular Edema 59 drug pipeline TAFA# 59 Drug Shows Promise